Dexmedetomidine Pathway, Pharmacokinetics/Pharmacodynamics

No Pathway Network information available for Dexmedetomidine Pathway, Pharmacokinetics/Pharmacodynamics

#	Name	Source	Genes
1	Dexmedetomidine Pathway, Pharmacokinetics/Pharmacodynamics	PharmGKB	ADRA2A UGT1A4 UGT2B10

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

#	Symbol	Description	Category	# Related Pathways
1	UGT2B10	UDP Glucuronosyltransferase Family 2 Member B10	Protein Coding	1
2	UGT1A4	UDP Glucuronosyltransferase Family 1 Member A4	Protein Coding	1
3	ADRA2A	Adrenoceptor Alpha 2A	Protein Coding	1

according to GeneCards Suite gene sharing

#	Disorder	Type	Genes	Score
1	Lipodystrophy, familial partial, type 8	Enrichment	ADRA2A	3.66
2	Crigler-najjar syndrome, type i	Enrichment	UGT1A4	2.66
3	Hyperbilirubinemia, transient familial neonatal	Enrichment	UGT1A4	2.66
4	Bilirubin, serum level of, quantitative trait locus 1	Enrichment	UGT1A4	2.66
5	Crigler-najjar syndrome, type ii	Enrichment	UGT1A4	2.66
6	Gilbert syndrome	Enrichment	UGT1A4	2.61
7	Bilirubin metabolic disorder	Enrichment	UGT1A4	2.61

¹ WikiPathways

² PubChem

³ R&D Systems

⁴ Reactome

⁵ GeneGo (Thomson Reuters)

⁶ QIAGEN

⁷ PharmGKB

⁹ Sino Biological

¹⁰ Tocris

¹¹ MalaCards

Pathway Network for Dexmedetomidine Pathway, Pharmacokinetics/Pharmacodynamics